KAINOS Laboratories (TSE:4556) Ending Cash Position: 円3,400 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4556 KAINOS Laboratories Inc TSE:4556
47 GF Score
Price 円2,268.00
GF Value 円1,285.89
! 6 Warning Signs
View Full Analysis

What is KAINOS Laboratories Ending Cash Position?

KAINOS Laboratories TSE:4556 47 Ending Cash Position is 円3,400 Mil as of Mar. 2026. GuruFocus rates TSE:4556 with a GF Score™ of 47/100 and a GF Value™ of 円1,285.89. The stock has 6 warning signs investors should review.

KAINOS Laboratories's Ending Cash Position for the quarter that ended in Mar. 2026 was 円3,400 Mil.

KAINOS Laboratories's quarterly Ending Cash Position declined from Mar. 2025 (円3,056 Mil) to Sep. 2025 (円2,967 Mil) but then increased from Sep. 2025 (円2,967 Mil) to Mar. 2026 (円3,400 Mil).

KAINOS Laboratories's annual Ending Cash Position increased from Mar. 2024 (円2,834 Mil) to Mar. 2025 (円3,056 Mil) and increased from Mar. 2025 (円3,056 Mil) to Mar. 2026 (円3,400 Mil).

KAINOS Laboratories Ending Cash Position Related Terms

KAINOS Laboratories Ending Cash Position Historical Data

* Premium members only.

The historical data trend for KAINOS Laboratories's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KAINOS Laboratories Ending Cash Position Chart

KAINOS Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,336.79 2,679.85 2,833.88 3,056.32 3,400.42

KAINOS Laboratories Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 384.92 2,770.71 3,056.32 2,967.11 3,400.42
TSE:4556
47GF Score
KAINOS Laboratories Inc TSE:4556
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

KAINOS Laboratories Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

KAINOS Laboratories's Ending Cash Position for the fiscal year that ended in Mar. 2026 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=3056.323+344.1
=3,400

KAINOS Laboratories's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=2967.112+433.311
=3,400

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of 円3,400 Mil mean?
KAINOS Laboratories (TSE:4556) has a Ending Cash Position of 円3,400 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on KAINOS Laboratories and its competitors.
Is KAINOS Laboratories' Ending Cash Position too high?
KAINOS Laboratories' current Ending Cash Position is 円3,400 Mil. Overall, KAINOS Laboratories has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does KAINOS Laboratories' Ending Cash Position compare to ISRG and BDX?
KAINOS Laboratories' Ending Cash Position of 円3,400 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Devices & Instruments company?
A good Ending Cash Position depends on the Medical Devices & Instruments industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on KAINOS Laboratories and its competitors. KAINOS Laboratories's current Ending Cash Position is 円3,400 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KAINOS Laboratories stock overvalued right now?
KAINOS Laboratories (TSE:4556) has a current Ending Cash Position of 円3,400 Mil. The stock's GF Value™ is 円1,285.89, compared to a current price of 円2,268.00 — trading 76.4% above its estimated fair value. The current Ending Cash Position is 円3,400 Mil. KAINOS Laboratories' overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For KAINOS Laboratories (TSE:4556), the current Ending Cash Position is 円3,400 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is KAINOS Laboratories (TSE:4556) Overvalued in 2026?

Based on GuruFocus' analysis, KAINOS Laboratories stock appears to be overvalued. The current stock price of 円2,268.00 is trading 76.4% above its estimated GF Value™ of 円1,285.89.

Key valuation signals for TSE:4556:

  • Ending Cash Position: 円3,400 Mil
  • GF Value™: 円1,285.89 vs. price of 円2,268.00 (76.4% above fair value)
  • GF Score™: 47/100 with 6 warning signs

No single metric tells the full story. See the TSE:4556 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

KAINOS Laboratories Business Description

Address 38-18, Hongo 2-chome, Bunkyo-ku, Tokyo, JPN
KAINOS Laboratories Inc is focused on the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products. It also manufactures, sells, and exports/imports physicochemical measuring equipment for medical use.
47GF Score

Get the complete analysis for TSE:4556

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,268.00
Price
円1,285.89
GF Value